Publications
Specialty
Search
Psych Congress Network
10/08/2024
While intensive treatments with psilocybin and the serotonin reuptake inhibitor (SSRI) escitalopram were associated with long-term improvements in major depressive disorder (MDD) symptom severity, recent phase 2 double-blind, randomized, controlled trial trial results.
Wound Care
10/08/2024
A 170-patient RCT will assess the efficacy of PCMP (PuraPly AM) and SoC vs SoC alone for treatment of chronic DFUs with primary outcome of percentage of ulcer closure at 12 weeks. Recruitement is ongoing with estimated study completion in Nov 2026. clinicaltrials.gov
First Report Managed Care
10/08/2024
Helicobacter pylori infection may curb the benefit of sleeve gastrectomy in patients with obesity and diabetes, according to a study published in the International Journal of Obesity.
Gastroenterology
10/08/2024
Researchers explored the use of an artificial intelligence model to detect metabolic dysfunction–associated steatotic liver disease.
EMSWorld
10/08/2024
On Tuesday, much of Florida was hunkering down for the looming arrival of Hurricane Milton, a Category 4 hurricane that could deliver the most damaging strikes to the state in history.
Advances in Inflammatory Bowel Disease Network
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Psych Congress Network
10/08/2024
Christoph Correll, MD, reviews some of the key prodromal and accentuated psychotic symptoms that serve as early indicators of schizophrenia.
Oncology
10/08/2024
According to phase 2 results, encorafenib plus binimetinib showed clinical activity for BRAF V600E-mutant advanced non-small cell lung cancer in the first-line setting.
Journal of Invasive Cardiology, CardioVascular
10/08/2024
Video Supplement to "Rotational Atherectomy for Treating Arterial Access-Site Stenosis Caused by Vascular Closure Device Failure Following Transcatheter Aortic Valve Replacement" (Clinical Image).
Journal of Invasive Cardiology, CardioVascular
10/08/2024
The authors describe 2 patients with arterial stenosis that was resistant to balloon dilation who were treated with rotational atherectomy.
Wounds
10/08/2024
This case study used a synthetic hybrid-scale fiber matrix in the management of recalcitrant pyoderma gangrenosum ulcers of the lower extremity.
Oncology, Journal of Clinical Pathways
10/08/2024
Abigail Zamorano, MD, MPHS, shares insights from a pilot study assessing a clinical algorithm, the the PREMM5 model, to evaluate a patient’s risk of carrying a Lynch Syndrome mutation, particularly in low-resource settings.
Vascular Disease Management, Journal of Invasive Cardiology, CardioVascular
10/08/2024
Medical device company marks trial milestone in the evaluation of its embolic protection device, creates expert advisory board as it navigates growth opportunity
Oncology
10/08/2024
True or False: According to an analysis of the Richter transformation subgroup from the p
Oncology
10/08/2024
At the 2024 SOHO meeting, Guillermo Garcia-Manero, MD, shared expert insight into treatment options for patients with high-risk myelodysplastic syndrome.
Psych Congress Network
10/08/2024
Continuing electroconvulsive therapy (ECT) after an acute ECT series is linked with lower rehospitalization risk compared with not continuing ECT, according to study results published in JAMA Psychiatry.
Oncology
10/08/2024
Sally Lau, MD, discusses results from the phase 1b DeLLphi-303 study which demonstrated that tarlatamab plus a PD-L1 inhibitor exhibited efficacy as a first-line maintenance therapy for patients with extensive-stage small cell lung cancer.
Gastroenterology
10/08/2024
Dr Hirsh Trivedi details how he approaches the diagnosis and management of metabolic-dysfunction associated fatty liver disease (MAFLD, formerly NAFLD) and metabolic associated steatohepatosis (MASH, formerly NASH.)
The Dermatologist
10/07/2024
This precision medicine approach to inflammatory skin disease prioritizes a view of the skin microbiome by utilizing bacteriophage therapy, the viruses that target and destroy specific strains of bacteria, based on individual patient skin swabs instead of broad-spectrum antibiotics.
First Report Managed Care
10/07/2024
The pulmonary arterial hypertension drug market is projected to grow to $11.6 billion by 2032, driven by an increase in pulmonary disorders, advancements in treatment options, and greater awareness of the condition.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
